Cerebral venous sinus thrombosis due to desogestrel intake in a young lady: A case report

Deepak Sharma1, Jay Tewari2, Shubhajeet Roy2

  • 1Department of Medicine Government Institute of Medical Sciences Greater Noida India.

Clinical Case Reports
|March 8, 2024
PubMed

Insights

Cerebral Venous Sinus Thrombosis (CVST) is a serious brain condition. Prompt diagnosis and treatment are crucial for young women using oral contraceptive pills who present with neurological symptoms.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Thrombosis Research

Background:

  • Cerebral Venous Sinus Thrombosis (CVST) is a rare but severe form of venous thromboembolism affecting the brain's dural sinuses.
  • CVST can lead to intracranial hemorrhage and stroke, irrespective of patient demographics.
  • Prompt thrombolysis is essential to mitigate neurological deficits.

Observation:

  • A 25-year-old female presented with severe headache, vomiting, seizures, and altered sensorium after two months of desogestrel use.
  • Clinical examination revealed unresponsiveness, fever, bilateral papilledema, and neurological deficits.
  • Imaging confirmed CVST, with elevated homocysteine levels noted.

Findings:

  • The patient was diagnosed with Cerebral Venous Sinus Thrombosis.
  • Elevated homocysteine levels were identified as a potential contributing factor.
  • The patient showed significant recovery with appropriate medical intervention.

Implications:

  • This case highlights the critical need to consider CVST in young women presenting with neurological dysfunction, particularly those using oral contraceptive pills.
  • Early clinical suspicion and diagnostic workup are vital for timely management.
  • Vigilant screening and prompt treatment can reduce mortality and morbidity associated with CVST.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
523
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
66
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
134
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K